Nava Almog

Summary

Affiliation: Tufts University
Country: USA

Publications

  1. pmc Prospective identification of glioblastoma cells generating dormant tumors
    Ronit Satchi-Fainaro
    Department of Physiology and Pharmacology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    PLoS ONE 7:e44395. 2012
  2. pmc Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype
    Nava Almog
    Center of Cancer Systems Biology, Steward Research and Specialty Projects Corp, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, Massachusetts, United States of America
    PLoS ONE 7:e44001. 2012
  3. doi request reprint Genes and regulatory pathways involved in persistence of dormant micro-tumors
    Nava Almog
    Tufts University School of Medicine, Boston, MA 02135, USA
    Adv Exp Med Biol 734:3-17. 2013
  4. doi request reprint Molecular mechanisms underlying tumor dormancy
    Nava Almog
    Center of Cancer Systems Biology, Caritas St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, MA 02135, United States
    Cancer Lett 294:139-46. 2010
  5. doi request reprint Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype
    Nava Almog
    Center of Cancer Systems Biology, Caritas St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02135, USA
    Cancer Res 69:836-44. 2009
  6. pmc Platelets actively sequester angiogenesis regulators
    Giannoula Lakka Klement
    Children s Hospital, Boston, MA 02115, USA
    Blood 113:2835-42. 2009
  7. ncbi request reprint Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis
    Nava Almog
    Vascular Biology Program and Department of Surgery, Children s Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA
    FASEB J 20:947-9. 2006
  8. ncbi request reprint A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype
    George N Naumov
    Department of Surgery, Children s Hospital, Harvard Medical School, Boston, MA, USA
    J Natl Cancer Inst 98:316-25. 2006
  9. ncbi request reprint Platelet-associated PF-4 as a biomarker of early tumor growth
    David Cervi
    Children s Hospital Boston, Karp Family Research Laboratories, Boston, MA 02115, USA
    Blood 111:1201-7. 2008
  10. pmc Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells
    Ofer Fainaru
    Vascular Biology Program and Department of Surgery, Childrens Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA
    FASEB J 24:1411-8. 2010

Collaborators

Detail Information

Publications12

  1. pmc Prospective identification of glioblastoma cells generating dormant tumors
    Ronit Satchi-Fainaro
    Department of Physiology and Pharmacology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    PLoS ONE 7:e44395. 2012
    ..Isolating the tumor cells that form dormant tumors will facilitate understanding of the underlying mechanisms of dormant micro-metastases, late recurrence, and changes in rate of tumor progression...
  2. pmc Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype
    Nava Almog
    Center of Cancer Systems Biology, Steward Research and Specialty Projects Corp, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, Massachusetts, United States of America
    PLoS ONE 7:e44001. 2012
    ..This work suggests novel means to reverse the malignant tumor phenotype into an asymptomatic dormant state and may provide promising targets for early detection or prevention of cancer...
  3. doi request reprint Genes and regulatory pathways involved in persistence of dormant micro-tumors
    Nava Almog
    Tufts University School of Medicine, Boston, MA 02135, USA
    Adv Exp Med Biol 734:3-17. 2013
    ....
  4. doi request reprint Molecular mechanisms underlying tumor dormancy
    Nava Almog
    Center of Cancer Systems Biology, Caritas St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, MA 02135, United States
    Cancer Lett 294:139-46. 2010
    ....
  5. doi request reprint Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype
    Nava Almog
    Center of Cancer Systems Biology, Caritas St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02135, USA
    Cancer Res 69:836-44. 2009
    ..These data will be instrumental in identifying novel early cancer biomarkers and could provide a rationale for development of dormancy-promoting tumor therapy strategies...
  6. pmc Platelets actively sequester angiogenesis regulators
    Giannoula Lakka Klement
    Children s Hospital, Boston, MA 02115, USA
    Blood 113:2835-42. 2009
    ....
  7. ncbi request reprint Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis
    Nava Almog
    Vascular Biology Program and Department of Surgery, Children s Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA
    FASEB J 20:947-9. 2006
    ....
  8. ncbi request reprint A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype
    George N Naumov
    Department of Surgery, Children s Hospital, Harvard Medical School, Boston, MA, USA
    J Natl Cancer Inst 98:316-25. 2006
    ..We previously demonstrated that human tumors contain tumor cell populations that are heterogeneous in angiogenic activity. Here, we separated angiogenic from nonangiogenic human tumor cell populations and compared their growth...
  9. ncbi request reprint Platelet-associated PF-4 as a biomarker of early tumor growth
    David Cervi
    Children s Hospital Boston, Karp Family Research Laboratories, Boston, MA 02115, USA
    Blood 111:1201-7. 2008
    ..We conclude that platelet-associated PF-4, but not its plasma counterpart, may represent a potential biomarker of early tumor presence...
  10. pmc Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells
    Ofer Fainaru
    Vascular Biology Program and Department of Surgery, Childrens Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA
    FASEB J 24:1411-8. 2010
    ..Thus, cancer immunotherapies that promote DC maturation may act by both augmenting the host immune response to the tumor and by suppressing tumor angiogenesis...
  11. pmc Systems biology of tumor dormancy: linking biology and mathematics on multiple scales to improve cancer therapy
    Heiko Enderling
    Center of Cancer Systems Biology, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02135, USA
    Cancer Res 72:2172-5. 2012
    ....